DP VII Associates L.P., 10% Owner at Orexigen Therapeutics, Inc. (OREX), bought 2,316 shares at $7.50 ($17K) on 2009-12-18, disclosed to the SEC on 2009-12-21.
Open-market purchase of $17k OREX by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.55 | 1,677 | $13K | 72.5% |
| 2 | $7.50 | 639 | $5K | 27.5% |
| Total | $7.54 avg | 2,316 | $17K | 100% |
| Filing → |
| EVOK | SELL | 2016-04-21 | $4K | — | Filing → |
| EVOK | SELL | 2016-04-08 | $5K | — | Filing → |
| ESPR | BUY | 2013-07-02 | $67K | — | Filing → |